Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...
DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...
The company’s business grew at a healthy clip, yet its stock price went sideways and its valuation fell. Something has to ...
In a report released on July 6, Joanne Wuensch from Citi reiterated a Buy rating on Dexcom, with a price target of $84.00. The company’s shares closed yesterday at $72.38. 55% O ...
URC champions Leinster begin their search for a fifth title away at ASM Clermont Auvergne the same day,while Connacht start ...
Bell Global Equities Fund, managed by Bell Asset Management, released its May investor update. A copy of the letter can be ...
Heald, a digital metabolic health platform, today announced that consumers who purchase a Dexcom Stelo or Abbott Lingo continuous glucose monitor (CGM) through Heald will now receive complimentary ...
Zacks Investment Research on MSN

Here's why DexCom (DXCM) is a strong growth stock

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The research service ...
FDA's crackdown on online ketamine retailers, unprecedented health care premium hikes, and more health news from Morning ...
The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...
Smartwatches still can’t measure blood sugar on their own, but AI-powered CGMs are changing how glucose data is tracked and ...